Bill and Coo formulations represent a systems-based approach to companion animal supplementation, designed to influence multiple physiological pathways rather than targeting isolated outcomes. These formulations are developed to support immune function, gastrointestinal balance, connective tissue integrity, and integumentary health through the use of bioavailable and synergistic ingredients. This integrated strategy reflects a shift toward functional nutrition, where supplementation is used to optimize biological systems at both the cellular and systemic level.

This paper evaluates the scientific foundation underlying each formulation within the Bill and Coo portfolio. Emphasis is placed on ingredient composition, mechanistic function, and clinical relevance within the context of modern veterinary nutrition. By examining how these formulations interact with key biological systems, this analysis highlights the role of targeted nutraceutical supplementation in supporting physiological resilience, maintaining homeostasis, and promoting long-term health outcomes in companion animals.

Earthworms (Annelida: Oligochaeta) exhibit robust regenerative abilities that vary across species, body regions, and evolutionary lineages. This manuscript synthesizes classical and contemporary research on annelid regeneration—including wound closure, immune activation, blastema formation, segment reconstruction, and ventral nerve cord regrowth—and integrates these mechanisms with ecological observations from Prince Edward Island (PEI) earthworm communities. Drawing from cellular, molecular, and transcriptomic studies, we outline the processes that enable successful regeneration and contrast them with taxa that have lost regenerative capacity. We also contextualize regeneration within earthworm immunity, extracellular matrix (ECM) remodelling, and segmental patterning. Figures illustrate the regeneration sequence, coelomocyte dynamics, molecular pathways, and comparative outcomes. This synthesis provides a mechanistic foundation for interpreting regeneration in PEI earthworm species and supports future ecological and applied research.
Keywords: earthworm regeneration; blastema; neuroregeneration; fibrosis; tissue engineering

The oral cavity is a mirror of systemic health and acts as a gateway for many systemic diseases. More than 700 bacterial species in oral cavity. Bacterial Species belongs to genera gemella, granulicatella, streptococcus salivarius, S. mitis, Actinomyces, Neisseria, Corynebacterium, haemophilus and veillonella There are approximately 10¹³ cells per gram of germs present from the mouth to the anus, indicating that the oral cavity is an important entry point of the gut system. Around 2 billion germs are present in the oral cavity.

The continuous emergence of drug resistance, limitations of conventional therapeutics, and the growing burden of infectious and chronic diseases have intensified the search for novel biological targets in medicinal chemistry. Emerging biological targets such as kinases, proteases, ion channels, and parasite-specific metabolic pathways have gained substantial attention due to their pivotal roles in cellular signaling, pathogen survival, and disease progression. Protein kinases regulate numerous intracellular pathways associated with cancer, inflammatory disorders, and neurodegenerative diseases, making them attractive targets for selective therapeutic intervention. Proteases are involved in viral replication, tumor metastasis, apoptosis, and microbial virulence, thereby offering opportunities for the development of protease inhibitors with broad clinical applications. Ion channels represent crucial membrane proteins that regulate electrical signaling, neurotransmission, and ion homeostasis, and their dysregulation has been implicated in cardiovascular, neurological, and metabolic disorders. In parasitic diseases, pathogen-specific metabolic pathways provide selective drug targets with minimal host toxicity, especially in malaria, leishmaniasis, and trypanosomiasis. This mini-review highlights recent advances in the identification and therapeutic exploitation of these emerging targets, discusses current challenges associated with selectivity and resistance, and summarizes modern strategies including structure-based drug design, computational modeling, and nanotechnology-assisted delivery systems. The review underscores the importance of integrating molecular biology, medicinal chemistry, and artificial intelligence-driven approaches to accelerate the discovery of safer and more effective therapeutics.
Keywords: Kinases; Proteases; Ion Channels; Parasite-Specific Pathways; Drug Discovery; Medicinal Chemistry; Targeted Therapeutics

Introduction: The objective of This study aimed to determine the prevalence of infant and child malnutrition and associated factors.
Materials and methods: An analytical cross-sectional study was conducted in the Bengamisa Health Zone with 167 households during the period from April 12 to June 25, 2025. Logistic regression was used to search for factors associated with child malnutrition.
Results: The overall prevalence of malnutrition was 15%, while the prevalence of moderate acute malnutrition was 8.3% and 7.1%, respectively, for severe acute malnutrition. Complete childhood vaccination (aOR=0.28; 95% CI: 0.13-0.41) and a “Good” overall maternal knowledge level (aOR=0.42; 95% CI: 0.28-0.56) reduced the risk of childhood malnutrition.
Conclusion: The overall prevalence of malnutrition remains high in all its forms. Complete childhood vaccination and maternal overall knowledge were associated factors. Mothers should be encouraged to continue CPS (Community-Based Post-Prevention) after their children have completed their vaccination schedule.
Keywords: Prevalence; malnutrition; associated factors; Tshopo

Introduction: Care of the full dentition involves Oral Hygiene practices which include brushing use of floss and irrigation. Aim: Discussion: The various methods available are reviewed and endorses the level of success by reaffirmation of the thoroughness of implementation by the subject. Conclusion: Thers is no best method for Plaque removal, but success depends on the proficiency used rather than the method.
Keywords: Brushing; biofilm; flossing; irrigation; oral-hygiene; plaque

Nanoscale engineering is one of the most transformative frontiers of modern science and advanced technology. By manipulating matter at dimensions typically between 1-100 nanometers (nm), scientists and engineers are architecting functionality at the level where quantum effects, surface phenomena, and molecular interactions dominate. At this scale, material properties substantially different from the bulk, opening various opportunities in various high-performance applications, including in energy, electronics, healthcare and in infrastructure [1].

As the construction industry grapples with the urgent need to reduce its environmental footprint, Geopolymer Concrete has emerged as a promising alternative to conventional Portland cement concrete. Unlike traditional concrete, which relies heavily on cement production (a major source of carbon dioxide emissions), Geopolymer Concrete utilizes industrial by products such as Fly Ash and Ground Granulated Blast Furnace Slag (GGBS) as binding materials along with alkaline solutions (Sodium Hydroxide and Sodium Silicate).

The integration of Large Language Models (LLMs) into multiagent systems has opened new possibilities for collaborative reasoning and cooperation with AI agents. This paper explores different prompting methods and evaluates their effectiveness in enhancing agent collaborative behaviour and decisionmaking. We enhance CoELA, a framework designed for building Collaborative Embodied Agents that leverage LLMs for multi-agent communication, reasoning, and task coordination in shared virtual spaces. Through systematic experimentation, we examine different LLMs and prompt engineering strategies to identify optimised combinations that maximise collaboration performance. Furthermore, we extend our research by integrating speech capabilities, enabling seamless collaborative voice-based interactions. Our findings highlight the effectiveness of prompt optimisation in enhancing collaborative agent performance; for example, our best combination improved the efficiency of the system running with Gemma3 by 22% compared to the original CoELA system. In addition, the speech integration provides a more engaging user interface for iterative system development and demonstrations.
Alice and Bob Voice Chat GUI Video demonstration.
Github link to codebase.
Keywords: Collaborative Embodied AI; co-operative AI; LLMs; evaluation

Over the years, the role of BIM has evolved from a coordination tool to a performance-driven design platform and is now becoming increasingly infused with artificial intelligence. This research explores the influence of BIM capability with AI technology on fenestration system performance and outcomes of the projects in the South Indian AEC sector. The method employed was quantitative where data were gathered from industry professionals of 300 respondents. Structural Equation Modeling (SEM) was used to analyze the data to assess the direct and indirect relationships. The results show that the use of AI-integrated BIM capability positively contributes to fenestration system performance (β = 0.64, p < 0.001), and fenestration performance positively affects the project outcomes (β = 0.58, p < 0.001). A significant amount of variance in fenestration performance (R² = 0.61) and project outcomes (R² = 0.68) is explained by the model. The mediation analysis results validated the partial mediation of fenestration performance between the capability of the AI-BIM and the project outcomes. Further, there are indications that BIM maturity and green building experience enhance the effectiveness of integrating AI in the moderate range of moderation results. The study is a contribution in creating a clear performance based trajectory between digital capabilities and project outcomes. The results underscore the importance of optimizing systems over just adopting the technology in the context of BIM and AI.
Keywords: AI-integrated BIM; fenestration systems; building performance; SEM; AEC sector; sustainability

Anthropogenic micropollutants such as pharmaceuticals and corrosion inhibitors are insufficiently removed in conventional wastewater treatment. This study evaluates three disinfection/oxidation methods applied to treated municipal wastewater in Kuopio, Finland: (1) ozone treatment using the SansOx OxTube hermetic dissolution system, (2) peracetic acid (PAA) combined with UV, and (3) hydrogen peroxide combined with UV. Eight substances exceeded 1 µg/L in the effluent. The OxTube-ozonation method achieved the highest removal efficiencies, including 99.9% removal of cetirizine, 99.7% of diclofenac, 99.7% of furosemide, 99.6% of losartan and 91.3% of venlafaxine. PAA+UV and H₂O₂+UV showed minimal or no removal. These results demonstrate that ozone-based advanced oxidation, when delivered through the SansOx OxTube system, provides a highly effective and scalable solution for reducing pharmaceutical residues in municipal effluents.
Keywords: Ozone; OxTube; SansOx; wastewater; pharmaceuticals; advanced oxidation; micropollutants; disinfection

Google alerts is a very fantastic platform to notify yours, whatever your curiosity contemplate information at-large scale Internet. What about their relevance and how to sustain them best-effort ?

Keywords: distributed event-based large scale software; information retrieval; digital literacy; publish/subscribe; information-centric networking; top-k relevance; recommendation algorithms; universal telecommunication service

Alcohol use disorder (AUD) remains a significant healthcare challenge due to its high prevalence, clinical complexity, and contribution to preventable illness and mortality worldwide. Despite widespread alcohol consumption and increasing healthcare utilization related to intoxication and chronic disease, treatment access remains limited, and current therapies primarily focus on behavioral modification or central nervous system pathways rather than addressing the physiological damage caused by alcohol metabolism.

The scientific foundation of alcohol-related harm centers on how ethanol is metabolized in the body. Alcohol is converted into acetaldehyde, a toxic intermediate that promotes oxidative stress, inflammation, mitochondrial dysfunction, and cellular injury. Variability in metabolic enzymes, influenced by genetics, liver health, and nutritional status, contributes to differences in intoxication severity and long-term health outcomes among individuals. Current pharmacologic treatments do not accelerate alcohol clearance or directly reduce metabolic toxicity, leaving an important gap in care.

The white paper introduces a patented Alcohol Metabolism Acceleration Composition designed to support endogenous enzymatic pathways involved in alcohol breakdown. By enhancing the function of alcohol dehydrogenase and aldehyde dehydrogenase, and incorporating antioxidant and metabolic cofactors, the composition aims to reduce acetaldehyde accumulation, shorten exposure to toxic metabolites, and promote metabolic balance. The proposed mechanism extends beyond liver detoxification and may influence systemic pathways, including gut-liver-brain interactions linked to cognitive and inflammatory effects.

Potential clinical applications include acute care settings, harm reduction strategies, and supportive use in individuals with metabolic vulnerability or limited treatment options. However, ethical and regulatory considerations emphasize that such interventions must be positioned as adjunctive tools rather than substitutes for treatment or encouragement of alcohol consumption. Safety monitoring, responsible use frameworks, and continued research are essential.

Overall, the paper highlights enzyme-driven metabolic support as an emerging innovation in healthcare. By targeting the physiological processes underlying alcohol-related harm, this approach may complement existing therapies, improve patient safety, and contribute to future advancements in precision medicine and harm reduction strategies.

Alcohol use disorder (AUD) represents a major global public health challenge, contributing to the loss of millions of lives worldwide. Despite its widespread prevalence, a substantial proportion of individuals affected by AUD do not receive appropriate or timely intervention. This significant treatment gap highlights the urgent need for expanded awareness, improved understanding, and the development of effective intervention strategies to address this critical health issue. Chronic alcohol consumption disrupts metabolic processes and adversely affects multiple organ systems, including the liver, brain, cardiovascular system, and gastrointestinal tract. Because alcohol is rapidly metabolized and widely distributed throughout the body, a comprehensive understanding of its metabolic pathways and of supportive interventions that may facilitate physiological recovery is essential. Furthermore, the complex interplay between alcohol metabolism, nutritional deficiencies, and natural or adjunctive therapeutic approaches presents valuable opportunities to address the multifactorial physiological challenges experienced by individuals with alcohol use disorder.

This white paper explores natural and integrative strategies for managing parasitic infections, which affect billions of people worldwide and remain a major global health challenge. While conventional antiparasitic drugs are essential, their effectiveness is increasingly limited by drug resistance, toxicity, incomplete parasite eradication, reinfection, and poor patient tolerance. These challenges highlight the need for adjunctive and complementary approaches that are safer, broader-acting, and more sustainable.

The paper focuses on bioactive natural compounds particularly curcumin, resveratrol, and vitamin C that demonstrate direct antiparasitic activity, along with anti-inflammatory, antioxidant, and immune-modulating effects. These compounds may enhance host defense, reduce parasite burden, and improve tolerance to pharmaceutical therapies.

Parasitic infections represent a significant and often underrecognized global health burden, affecting billions of individuals worldwide and contributing to substantial morbidity and mortality, particularly in vulnerable and resource-limited populations. These infections can impair immune function, disrupt gastrointestinal and metabolic health, and exacerbate chronic disease states, placing long-term strain on both individuals and healthcare systems. While conventional pharmaceutical antiparasitic therapies remain a cornerstone of treatment, their effectiveness is increasingly challenged by factors such as drug resistance, limited efficacy across parasite species, adverse side effects, and concerns related to overuse and misuse.

In response to these limitations, a growing body of scientific literature has begun to explore the role of naturally derived compounds as complementary or alternative strategies for parasite management. Bioactive plant compounds and micronutrients have demonstrated antiparasitic, anti-inflammatory, antioxidant, and immunomodulatory properties that may enhance host defense mechanisms while reducing treatment-related burden. This white paper examines the current scientific evidence supporting natural antiparasitic interventions, with specific focus on curcumin, resveratrol, and vitamin C. Emphasis is placed on their mechanisms of action, documented efficacy against parasitic organisms, and their potential role as adjunctive agents alongside conventional therapies, offering a more integrative and systems-based approach to parasite control.

This research offers an extensive and interdisciplinary exploration of biohacking as a transformative paradigm for healthy aging, longevity, and optimized human performance. At the core of this investigation is the strategic use of natural, root-derived compounds alongside plant-, herb-, and mineral-based bioactives as foundational tools within biohacking frameworks. By integrating contemporary scientific research, ancestral healing traditions, and emerging biohacking technologies, the study presents biohacking as a systems-based approach that addresses the interconnected dimensions of emotional, mental, physical, psychological, spiritual, metabolic, and sexual health. The paper examines how biohacking methodologies such as personalized nutrition, targeted supplementation, physical training, sleep optimization, stress regulation, cognitive enhancement, environmental awareness, and mindfulness practices interact synergistically with natural compounds to influence cellular health and biological resilience. Emphasis is placed on understanding how these interventions support mitochondrial efficiency, hormonal balance, immune function, neuroplasticity, metabolic regulation, and cellular repair. Rather than framing longevity solely as the extension of lifespan, this research prioritizes healthspan, underscoring the importance of maintaining functional capacity, vitality, and quality of life throughout the aging process. Mental and emotional health are explored as central pillars of sustainable longevity. The research highlights how biohacking strategies that incorporate natural root-derived compounds may contribute to emotional stability, cognitive clarity, stress adaptability, and protection against age-associated cognitive decline. The study further investigates how nootropic-supportive nutrients, antioxidant-rich botanicals, and neuroprotective dietary patterns may enhance memory, attention, learning capacity, and mental sharpness across the lifespan.

This paper presents a comprehensive overview of the human respiratory system, focusing on anatomical structure, physiological function, and regulatory mechanisms that sustain breathing and systemic homeostasis. The discussion outlines the airflow pathway beginning at the nasal passages, where filtration, humidification, and defense against airborne particles occur, and continues through the pharynx, larynx, trachea, bronchi, and bronchioles to the alveolar respiratory zone. Within the lungs, gas exchange is facilitated by alveoli and pulmonary capillaries, allowing oxygen uptake and carbon dioxide removal while supporting cellular energy production and metabolic balance. Structural protection is provided by pleural membranes and coordinated pressure dynamics involving atmospheric, intrapulmonary, and intrapleural forces, which together regulate ventilation efficiency. The autonomic nervous system contributes to airway tone, glandular activity, and muscular coordination, ensuring stable respiratory rhythm and functional equilibrium between pulmonary and systemic circulation. Additional roles of the respiratory system include maintenance of acid base balance, thermoregulation, and support of overall physiological resilience. The paper also highlights the importance of preserving respiratory health through environmental awareness, physical activity, and preventative care. By integrating anatomical detail with functional mechanisms, this work emphasizes the critical role of respiration in sustaining vitality, maintaining internal stability, and supporting long term human health.

Alzheimer’s disease is a growing global public health concern, affecting millions of individuals worldwide and imposing substantial emotional, social, and economic burdens on patients, caregivers, and healthcare systems. As population aging continues to accelerate, the prevalence of Alzheimer’s disease is expected to rise, underscoring the increasing importance of strategies aimed at preserving cognitive function and delaying disease onset. Evidence suggests that Alzheimer’s disease is multifactorial in nature, with contributions from genetic predisposition, lifestyle choices, and environmental exposures. Importantly, many of these factors are modifiable, providing a critical opportunity for early intervention. Integrative and holistic approaches including targeted nutrition, regular physical activity, cognitive and mind-body therapies, sleep optimization, and selected herbal or natural supplements have demonstrated potential in supporting neuroplasticity, reducing oxidative stress, and enhancing overall brain resilience. Nutritional patterns such as the Mediterranean and MIND diets, combined with routine aerobic and resistance exercise, ongoing mental stimulation, meditation, and adequate sleep, may play a meaningful role in maintaining cognitive health. Additionally, certain natural compounds may offer complementary neuroprotective benefits. While limitations in study design and variability in evidence quality warrant cautious interpretation, holistic interventions can serve as valuable adjuncts to conventional medical care. Personalized, lifestyle-based strategies hold promise for reducing Alzheimer’s disease risk, supporting cognitive well-being, and improving quality of life for both patients and caregivers, while also contributing to broader public health efforts aimed at mitigating the growing burden of neurodegenerative disease.

Breast cancer is one of the most prevalent and biologically complex malignancies worldwide, requiring treatment strategies that extend beyond tumor eradication to account for individual patient variability and the potential toxicities associated with therapy. Surgery, radiotherapy, chemotherapy, endocrine therapy, targeted agents, and immunotherapy have made a lot of improvements to the survival rates of various subtypes of breast cancer. Nevertheless, these treatments are often linked to systemic side effects, immunosuppression, metabolic imbalance, and reduced quality of life. The necessity to maintain patient resilience in the context of extended treatment courses has become more evident as the survival rates are increasing. Adjunctive therapies that regulate tumor-promoting biological pathways with an augmentation of treatment tolerance can hence be found in integrative oncology. This white paper will look at a patented proprietary formulation/treatment protocol that was designed as an adjunctive therapy in the case of breast cancer. The method involves the use of five synchronized formulations made of natural bioactive compounds, micronutrients, prebiotics, and phytochemicals, and applied using a structured, time-based dosing schedule.  The patented technique is based on emerging scientific data on modulation of inflammation, regulation of oxidative stress, immune support, metabolic optimization, and gut-tumor axis interactions. Instead of presenting its invention as a curative intervention, it is specifically made to be used with the known oncologic therapies. It aims at sustaining physiological systems that are mostly suppressed in the normal course of cancer treatment. This paper discusses the scientific reason, mechanical plausibility, formulation synergy, and clinical relevance of the patented strategy.

Childhood alopecia, particularly alopecia areata (AA), presents significant medical and emotional challenges, as the immune system mistakenly targets growing hair follicles. The condition is often unpredictable, and many standard therapies fail to provide sustained long-term success. Conventional treatments may pose increased risks in pediatric populations, highlighting the need for safer and more supportive approaches that assist the body’s natural regulatory processes. Increasingly, clinicians are exploring integrative treatment strategies that consider immune balance, nutrition, and hormonal regulation. This white paper evaluates a newly patented treatment method that outlines a structured therapeutic plan for alopecia in children. The review examines whether the proposed approach is scientifically plausible for pediatric alopecia by analyzing current evidence in immunology, dermatology, nutritional science, and neuroimmune research. The findings suggest that gradual dosing, combined nutritional support, and immune-modulating components provide a reasonable mechanistic framework that may explain observed treatment outcomes while maintaining an emphasis on safety in children.

This comprehensive review examines the structure, function, regulation, and pathology of the circulatory and cardiovascular systems, emphasizing their essential role in maintaining systemic homeostasis. The cardiovascular system, composed of the heart and an extensive network of arteries, veins, and capillaries, supports oxygen delivery, nutrient transport, waste removal, hormonal signaling, immune defense, and fluid balance. Systemic and pulmonary circulations function as interdependent pathways that ensure continuous gas exchange and tissue perfusion.

Pulmonary circulation operates as a low-pressure, high-compliance system designed to optimize gas exchange while minimizing fluid accumulation. Pressure gradients, gravitational influences, and adaptive mechanisms such as capillary recruitment allow the lungs to accommodate increases in cardiac output without substantial elevation in pulmonary arterial pressure. Structural features, including pulmonary arteries, veins, lymphatics, and bronchial circulation, contribute to efficient oxygenation and fluid regulation. Disruption of pulmonary vascular integrity may result in conditions such as pulmonary edema, embolism, hypertension, and pleural effusion.

Systemic circulation distributes oxygenated blood throughout the body and returns deoxygenated blood to the heart. Vascular structure is closely adapted to function, with arteries designed to withstand high pressure, arterioles regulating resistance, capillaries facilitating exchange, and veins serving as capacitance reservoirs that support venous return. Vessel wall organization into tunica intima, media, and externa reflects mechanical and regulatory demands. Specialized microstructures such as vasa vasorum and nervi vasorum maintain vessel wall integrity and vascular tone.

The heart functions as a coordinated four-chambered pump with structurally specialized valves and conduction pathways that ensure unidirectional blood flow. Cardiac muscle histology, intrinsic pacemaker activity, and autonomic modulation collectively regulate the cardiac cycle. Electrical impulses generated in the sinoatrial node propagate through the atrioventricular node and conduction fibers to produce synchronized atrial and ventricular contraction. Neural, hormonal, and baroreceptor-mediated reflex mechanisms continuously adjust cardiac output to meet metabolic demands. Age-related changes influence myocardial compliance, adaptability, and coronary perfusion, though resting cardiac output is generally preserved in healthy individuals.

Disorders of the cardiovascular system arise from structural, electrical, metabolic, and inflammatory disturbances. Coronary artery disease remains a leading cause of morbidity and mortality and develops primarily through atherosclerotic plaque formation that restricts coronary blood flow. Additional contributors to cardiovascular risk include hypertension, dyslipidemia, diabetes mellitus, smoking, obesity, chronic stress, and advancing age. Congestive heart failure results from impaired ventricular function and progressive structural remodeling, while valvular disease alters hemodynamic efficiency through regurgitation or stenosis.

Vascular diseases encompass arterial narrowing, aneurysms, venous thrombosis, chronic venous insufficiency, vasculitis, and congenital malformations. Atherosclerosis underlies many arterial disorders, while venous pathologies often involve impaired valve function or clot formation. Capillary exchange dynamics, endothelial signaling, and inflammatory pathways contribute to both protective and pathological processes.

Blood itself is a dynamic tissue composed of plasma and formed elements. Red blood cells facilitate oxygen transport through hemoglobin-mediated binding and release, while white blood cells provide immune surveillance and defense. Platelets play central roles in hemostasis, inflammation, and vascular repair through complex granule release and receptor-mediated signaling pathways. Plasma maintains osmotic balance, transports proteins and hormones, and supports coagulation and immune responses.

Hematologic and immunologic disorders, including anemia, thrombocytopenia, leukopenia, and antiphospholipid syndrome, further illustrate the interconnected nature of circulatory physiology. Advances in gene therapy offer emerging therapeutic potential for inherited disorders such as hemophilia, sickle cell disease, and beta thalassemia, highlighting the evolving interface between molecular biology and cardiovascular medicine.

Overall, the circulatory and cardiovascular systems demonstrate remarkable structural specialization, regulatory precision, and adaptive capacity. Their coordinated function is essential for sustaining life, and disruption at any level, molecular, cellular, vascular, or cardiac, can produce widespread systemic consequences.

The domain of Otorhinolaryngology, encompassing conditions affecting the Ear, Nose, and Throat (ENT), encompasses a diverse array of medical ailments that exert a substantial influence on crucial sensory organs and their associated functions within the human body. The significance of comprehending and addressing these ENT diseases must be considered, given their profound effects on fundamental sensory perception, communication abilities, and overall well-being. This section explores the importance of ENT diseases, shedding light on their prevalence, impact on daily life, and the necessity for conventional and unconventional therapeutic approaches.

Fertility challenges are becoming increasingly common worldwide, with one in six adults experiencing infertility at some point in their lives. The environmental factors, such as toxic exposures, greatly contribute to this rise. The decrease in reproductive health, especially as a result of heavy metals, endocrine-disrupting chemicals, pesticides, and pollutants, has led to the need to enhance fertility more than ever. Although factors that cause infertility are environmental and lifestyle-based, natural products that are made using certain ingredients may help the natural fertility processes in the body. This white paper discusses the effectiveness of certain constituents within fertility-enhancing products as far as improvement in reproductive health is concerned. It dwells upon the ability of these ingredients to fight the negative impact of environmental toxins, de-toxify the body, balance hormones, and alleviate oxidative stress. With the help of the analysis of the ingredients of the products targeted at fertility support, we will be able to learn more about the potential role of the products in the development of fertility.

Hypertension, or high blood pressure, is a chronic and progressive condition that represents one of the most significant modifiable risk factors for cardiovascular morbidity and mortality worldwide. It is a leading contributor to heart disease, stroke, chronic kidney disease, heart failure, and vascular dementia. In the United States alone, nearly one in three adults is affected, and prevalence continues to rise due to aging populations, sedentary lifestyles, poor dietary patterns, obesity, chronic stress, and metabolic disorders (WHO, 2025). Often referred to as the “silent killer,” hypertension frequently presents without noticeable symptoms, allowing vascular damage to accumulate quietly over years before manifesting as a major cardiovascular event. Despite widespread awareness and the availability of effective pharmacologic therapies, blood pressure control rates remain suboptimal. A substantial percentage of hypertensive individuals either remain undiagnosed, undertreated, or non-adherent to prescribed treatment plans. Barriers to optimal control include inconsistent monitoring, limited patient engagement, therapeutic inertia, socioeconomic disparities, medication side effects, and inadequate lifestyle modification. As a result, uncontrolled hypertension significantly increases hospitalizations, disability-adjusted life years (DALYs), and premature mortality.

The economic burden of hypertension is equally profound. Direct medical costs including hospital admissions, emergency care, medications, and outpatient visits combine with indirect costs such as lost productivity, disability, and long-term care. Collectively, these factors place significant strain on healthcare systems and national economies. Preventive strategies and improved management protocols therefore represent both a clinical and financial imperative.

In recent years, advancements in digital health technologies have transformed the landscape of hypertension management. Home blood pressure monitoring, supported by connected health platforms such as the IDEAL LIFE hypertension management system, has emerged as an evidence-based strategy to improve patient outcomes. Remote monitoring enables real-time data transmission, continuous trend analysis, and early detection of blood pressure variability. This facilitates timely clinical intervention, medication adjustments, and personalized feedback ultimately enhancing adherence and empowering patients to take an active role in their care.

Moreover, integrating technology with structured interval interventions including lifestyle coaching, dietary counseling (e.g., DASH diet adherence), physical activity tracking, stress management, and medication optimization creates a comprehensive and proactive management model. Data-driven insights allow healthcare providers to identify patterns, address modifiable risk factors, and prevent hypertensive crises before complications occur. Studies consistently demonstrate that patients engaged in remote monitoring programs achieve improved blood pressure control, reduced emergency visits, and greater long-term cardiovascular risk reduction compared to standard care alone. This white paper examines the epidemiology of hypertension, its clinical and economic consequences, and current evidence-based management strategies. It further explores how digital health solutions and real-time monitoring technologies can enhance treatment adherence, optimize therapeutic outcomes, and reduce healthcare costs. By bridging traditional clinical care with innovative monitoring systems, hypertension management can evolve from reactive treatment to proactive, precision-based cardiovascular prevention ultimately reinforcing overall vascular health, longevity, and quality of life.

Fluoroquinolone antibiotics (FQs) are a class of broad-spectrum antimicrobial agents widely prescribed for respiratory, urinary tract, gastrointestinal, dermatologic, and systemic infections. Commonly utilized agents include ciprofloxacin, levofloxacin, and moxifloxacin. Due to their high bioavailability, excellent tissue penetration, and potent bactericidal activity, fluoroquinolones have become a mainstay in modern infectious disease management. However, while clinically effective, a growing body of scientific literature and post-marketing surveillance data has raised significant concerns regarding their safety profile. In certain individuals, fluoroquinolones have been associated with multisystem, persistent, and sometimes disabling adverse effects that extend well beyond the period of active treatment. These reactions may involve the neurological, musculoskeletal, mitochondrial, connective tissue, and autonomic nervous systems. Regulatory agencies, including the U.S. Food and Drug Administration (FDA), have issued multiple safety communications acknowledging risks such as tendon rupture, peripheral neuropathy, central nervous system effects, dysglycemia, and aortic complications. A subset of patients experiencing prolonged or severe adverse reactions frequently describe themselves as being “floxed,” a term coined within patient communities to describe fluoroquinolone-associated toxicity (FQT). Symptoms may emerge during treatment or develop weeks to months after discontinuation, and in some cases persist for years. Reported manifestations include chronic fatigue, tendon pain or rupture, neuropathy, cognitive impairment, dysautonomia, insomnia, anxiety, muscle weakness, and gastrointestinal disturbances. Increasing evidence suggests that these clinical presentations may be linked to mitochondrial dysfunction, oxidative stress, metal chelation, collagen degradation, altered gene expression, and immune dysregulation.

Forensic medicine serves as a critical intersection between medical science and the legal system, providing essential insights into cause of death, injury mechanisms, and identification of individuals. Traditionally grounded in pathology, toxicology, and molecular biology, the field has evolved with advances in scientific methodologies. Recently, interest has emerged in integrating non-traditional approaches including natural compounds such as resveratrol, curcumin, aloe vera, L-theanine, black cumin seed oil, pine bark extract, and velvet bean into forensic applications. This literature review evaluates both traditional and non-traditional approaches in forensic medicine, emphasizing their global relevance, biochemical mechanisms, and potential contributions to postmortem preservation, toxicological interpretation, and practitioner well-being. The review also examines the physiological and pathological aspects of drowning as a model forensic condition. Findings suggest that while traditional methods remain foundational, emerging natural compounds may offer complementary benefits in tissue preservation, oxidative stress reduction, and stress management. However, further validation and standardization are required to ensure scientific reliability and legal admissibility.

Intestinal disorders including inflammatory bowel diseases, functional gastrointestinal conditions, and colorectal cancer represent a growing global challenge for healthcare systems. Conventional treatment approaches primarily focus on symptom management and are often associated with limited long-term efficacy, undesirable side effects, or both. This white paper presents a novel, integrative therapeutic framework based on a patented set of formulations and dosing strategies designed to support intestinal health through the synergistic action of natural compounds, essential micronutrients, and bioactive plant-derived constituents. Grounded in emerging research from nutritional science, phytotherapy, and gut microbiome studies, this approach demonstrates potential anti-inflammatory, antioxidant, prebiotic, and immunomodulatory effects. The paper translates complex patent language into a clinically accessible and scientifically grounded framework, situating the formulation within the broader body of gastrointestinal health literature. It further explores proposed mechanisms of action, summarizes preliminary clinical observations, and outlines considerations for future research and potential clinical applications.

Senile dementia represents a complex neurodegenerative condition driven by multiple overlapping biological mechanisms, including amyloid-β deposition, tau pathology, oxidative stress, neuroinflammation, vascular dysfunction, and blood-brain barrier disruption. Because of this multifactorial nature, therapeutic strategies have increasingly shifted away from single-target pharmacology toward integrated, formulation-driven approaches. This white paper examines evolving treatment methodologies that combine traditional pharmacological agents, disease-modifying biologics, advanced drug-delivery technologies, nutraceutical interventions, hormonal and psychiatric symptom management, and non-pharmacological care models.

Current pharmacological therapies, including cholinesterase inhibitors and NMDA receptor antagonists, remain foundational but demonstrate limitations when used alone. Advances in formulation science, such as transdermal, intranasal, and nanoparticle-based delivery systems, aim to improve central nervous system penetration, bioavailability, and tolerability while reducing systemic adverse effects. Disease-modifying therapies targeting amyloid and tau proteins highlight a transition toward pathophysiological treatment, though challenges related to timing, safety, and brain penetration persist.

Nanotechnology and multimodal delivery platforms represent a significant area of innovation, enabling targeted drug transport across the blood-brain barrier and supporting sustained therapeutic release. Complementary strategies incorporating herbal, nutraceutical, and traditional medicine models are also explored, particularly when enhanced by modern formulation technologies that improve stability and absorption. In addition, management of psychiatric symptoms, hormonal influences, and individualized non-pharmacological care strategies contribute to a more comprehensive therapeutic framework.

Overall, the findings emphasize that successful dementia management relies on multimodal, person-centered interventions that integrate biological targeting with advanced formulation science. Future therapeutic development will likely depend on collaborative approaches that combine pharmacology, delivery innovation, and holistic care strategies to address the complexity of senile dementia.

Nutritional supplementation in companion animals has progressed from basic dietary fortification to the development of highly targeted, function-driven formulations designed to influence complex physiological systems. Modern nutraceutical strategies extend beyond the prevention of overt deficiencies, focusing instead on optimizing biological function at both the cellular and systemic levels. These formulations are increasingly designed to support immune regulation, metabolic efficiency, gastrointestinal balance, and integumentary integrity through the incorporation of bioactive and synergistic compounds.

This paper presents a comprehensive synthesis of current evidence surrounding key nutraceutical ingredients utilized in veterinary supplementation, including trace minerals, antioxidants, collagen peptides, prebiotic fibers, phytochemicals, and metabolic cofactors such as nicotinamide adenine dinucleotide (NAD+). Particular attention is given to the mechanistic pathways through which these compounds exert their effects, as well as their clinical relevance in supporting health across different life stages. The integration of these ingredients reflects a broader shift toward precision nutrition and preventative care in companion animal health, where targeted supplementation plays a role in maintaining long-term physiological balance.

Personalized medicine, especially genetic testing, is one of the innovations that has transformed how individuals understand their genetic makeup and how it influences their wellbeing. Knowledge about genetic predispositions can help avoid certain illnesses and make suitable decisions regarding nutrition, exercise, and other aspects of living. This approach is more useful than the general model where the same treatment regimen is applied to all the patients involved. The DRC-Gx product line exemplifies this innovation, offering six specialized programs: The products are DRC-GxNutrient, DRC-GxPerform, DRC-GxSlim, DRC-GxRenew, DRC-GxCBD and DRC-GxCannabis. All of them are designed to address different health issues and fulfill individual requirements based on the genetic information.

The information that could be used contained in the genetic data cannot be overemphasized. The DRC products provide a quantitative assessment of the vast area of health, such as nutrient metabolism, exercise performance, body composition, and gastrointestinal function. For instance, DRC-GxNutrient is created for enhancing micronutrient utilization while DRC-GxPerform incorporates exercise techniques for enhanced performance. In the same manner, DRC-GxSlim offers recommendations on how to lose weight based on genetic makeup and DRC-GxRenew offers aspects to do with aging. Indeed, such knowledge may contribute to the creation of measures that would have a positive impact on the state of health and quality of life. The integration of the genetic testing in the PHM is a major advance to achieving maximum health and fitness for every individual according to DNA constitution.

This paper explores the potential role of natural ingredients as complementary strategies for supporting individuals with Autism Spectrum Disorder (ASD). ASD is a complex neurodevelopmental condition characterized by differences in communication, behavior, and neurological processing, with presentations that vary widely among individuals. While autism has no known cure, current management approaches emphasize behavioral therapies, educational interventions, and symptom-focused medical support. Increasing scientific interest has focused on the integration of vitamins, minerals, and bioactive compounds to support cognitive function, behavioral regulation, emotional balance, and gastrointestinal health alongside conventional care.

The review highlights several micronutrients, including zinc, magnesium, and selenium, which contribute to neurological signaling, antioxidant defense, and immune regulation. Deficiencies in these nutrients may influence cognitive performance, mood, and behavioral stability. Antioxidant compounds such as vitamin C, raspberry polyphenols, resveratrol, and curcumin are discussed for their roles in reducing oxidative stress and neuroinflammation, processes frequently examined in ASD research. Additional ingredients, including orthosilicic acid, algae-derived antioxidants, L-theanine, N-acetyl-L-tyrosine, and plant extracts, are presented as potential contributors to cognitive support through mechanisms related to neurotransmitter balance, circulation, and cellular energy metabolism.

The paper also examines ingredients associated with behavioral regulation and mood stabilization, including D-ribose for cellular energy production and black seed oil for its anti-inflammatory and immunomodulatory properties. These compounds may influence neurological pathways linked to attention, fatigue, and emotional regulation. Furthermore, digestive health is emphasized as a key component of overall well-being in ASD, with ingredients such as bovine colostrum, collagen, pine bark extract, psyllium husk, and flaxseed discussed for their potential roles in supporting gut integrity, microbiota balance, and immune function through the gut–brain axis.

Overall, the paper concludes that natural ingredients may serve as supportive adjuncts to traditional therapies by addressing interconnected physiological systems involved in ASD. Although preliminary research suggests potential benefits across cognitive, behavioral, and gastrointestinal domains, further clinical investigation is needed to clarify mechanisms, dosing strategies, and individualized applications. Integrative approaches combining nutritional support with established therapeutic interventions may contribute to improved functional outcomes and quality of life for individuals across the autism spectrum.

This white paper presents gingivitis as more than a minor oral health issue, describing it as the earliest and reversible stage of periodontal disease as well as a meaningful indicator of broader systemic inflammation. While gingivitis has traditionally been understood as a localized reaction to plaque and bacterial biofilm buildup, the paper explains that current research increasingly connects gingival inflammation to immune dysfunction, oxidative stress, and chronic inflammatory burden throughout the body. Because the gums are highly vascularized, bacterial toxins and inflammatory mediators can enter systemic circulation, linking oral inflammation to wider health concerns such as cardiovascular disease, insulin resistance, and neuroinflammation.

The paper emphasizes that gingivitis develops through a multifactorial process involving both local and systemic contributors. Plaque accumulation and oral microbial imbalance are central drivers, but nutritional deficiencies, smoking, hormonal changes, chronic stress, and hyperglycemia can all worsen tissue vulnerability and immune dysregulation. A key focus is placed on the oral microbiome, which under healthy conditions helps maintain mucosal integrity and immune balance, but under dysbiotic conditions promotes chronic inflammation through pathogenic biofilms and endotoxin production. The paper also highlights the role of major inflammatory pathways, particularly NF-κB signaling, oxidative stress, and cytokine activity, in sustaining tissue damage and impairing repair.

In addition to explaining the biological mechanisms involved, the paper outlines the subtle but important clinical signs of gingivitis, including redness, swelling, bleeding, halitosis, and early tissue texture changes. Because these symptoms are often painless, gingivitis is frequently overlooked until it progresses into more advanced periodontal disease. The paper further strengthens its argument by exploring the growing body of evidence linking gingivitis to systemic health conditions, particularly cardiovascular and metabolic disorders, while also noting the possible contribution of environmental toxic exposures such as heavy metals.

The final sections contrast standard dental treatment with a broader systems-based supportive model. Conventional care, including scaling, root planing, brushing, flossing, and antimicrobial rinses, remains essential for removing plaque and controlling biofilm. However, the paper argues that these methods alone may not fully address the internal biological conditions that allow inflammation to persist or return. For this reason, it proposes an integrated model that combines conventional dental care with nutritional, microbiome, immune, and connective tissue support. Specific ingredients and products are presented as part of a protocol designed to reduce toxic burden, support microbial balance, strengthen tissue repair, and modulate inflammation.

Overall, the white paper concludes that gingivitis should be treated as both a local oral condition and an early marker of systemic imbalance. A dual-paradigm approach that combines mechanical dental treatment with deeper biological support may offer a more comprehensive and sustainable strategy for reducing inflammation, protecting periodontal structures, and supporting long-term whole-body health.

This paper examines evidence-based nutraceutical alternatives to glucagon-like peptide-1 (GLP-1) receptor agonists for weight management and metabolic health. While GLP-1 therapies are effective for appetite suppression and glycemic control, their use is often limited by adverse gastrointestinal effects, injectable administration, high cost, and clinically significant loss of lean muscle mass, which can compromise metabolic rate and long-term weight maintenance.

The paper introduces two nutraceutical formulations, Sculpt and Crush, designed to address these limitations through physiological rather than pharmacologic mechanisms. Sculpt focuses on appetite, glucose, and craving regulation by enhancing upstream metabolic communication between the gut, pancreas, liver, and central nervous system. Its botanical components support glycemic stability, satiety signaling, stress modulation, and gut–brain communication without directly suppressing hunger. Key ingredients, including Gymnema sylvestre, white kidney bean extract, ginger root, adaptogenic botanicals, and valerian root, are supported by clinical and systematic review evidence for their roles in glucose regulation, appetite modulation, metabolic efficiency, and stress-related eating behaviors.

Crush addresses one of the most significant challenges associated with GLP-1 therapies: lean muscle loss during rapid weight reduction. By supplying essential amino acids, β-hydroxy-β-methylbutyrate (HMB), and mitochondrial and antioxidant support, Crush is formulated to preserve muscle mass, maintain metabolic rate, and protect cellular energy systems during caloric restriction. These components are supported by human clinical trials and meta-analyses demonstrating benefits in muscle preservation, strength, and metabolic resilience.

Together, Sculpt and Crush offer a complementary, evidence-based nutraceutical approach to weight management that emphasizes metabolic communication, muscle preservation, and long-term metabolic health. Rather than suppressing hunger through pharmacologic intervention, this strategy supports sustainable weight control through physiological signaling pathways, without injections or compromised metabolic outcomes.

A consistent supply of energy is more challenging to attain than many assume. High-fructose gels precipitate glucose and consequently decay rapidly. Ketone beverages may be smoother and usually do not upset the stomach. Another way is a raw honey-b-hydroxybutyrate (BHB) composition. Honey provides glucose and fructose to give direct glycolysis. BHB salts elevate the circulating ketones to be oxidized later. The hypothesis is that a controlled single dose of dual-fuel can enhance metabolic flexibility, gastrointestinal comfort, and functional product. In the present paper, the biochemical explanation, health-oriented benefits assessment, and medically relevant implications in the case of responsible consumption are described. It also defines the limits of dosing, safety indicators, and priorities to be validated.

This scientific white paper explores how functional nutritional ingredients contribute to the health, resilience, and longevity of dogs and cats. Rather than focusing only on basic nutrient requirements, the paper highlights how specific bioactive compounds influence immune function, oxidative balance, digestion, structural integrity, and metabolic health at cellular and molecular levels.

Micronutrients such as vitamins A, C, D, and E, along with trace minerals including zinc, selenium, and magnesium, play essential roles in immune regulation and metabolic processes. Adequate intake supports enzyme activity, cellular signaling, and immune responsiveness, helping maintain physiological balance and reduce vulnerability to illness.

Antioxidants help counteract oxidative stress caused by reactive oxygen species, which can damage tissues and contribute to inflammation and chronic disease. Nutritional antioxidants support cellular integrity, immune stability, and healthy aging, particularly in animals exposed to environmental stressors or inflammatory conditions.

Omega-3 fatty acids influence immune signaling, gene expression, and inflammatory pathways. Their inclusion in companion animal nutrition is associated with support for skin health, joint function, cardiovascular balance, and overall immune regulation through mechanisms that promote balanced inflammatory responses.

Dietary fibers and prebiotics play a central role in gastrointestinal health by shaping the gut microbiome, improving stool quality, and strengthening intestinal barrier integrity. Research demonstrates that these ingredients support immune function through microbial interactions and the production of beneficial metabolites such as short-chain fatty acids.

Flavonoids, tannins, and other plant compounds contribute antioxidant and immunomodulatory activity. These phytonutrients influence immune signaling pathways, metabolic health, and detoxification processes, supporting a holistic approach to nutritional wellness in companion animals.

Structural nutrients such as collagen and silicon-containing compounds support connective tissue strength, skin integrity, and joint stability. These components may aid mobility and recovery by maintaining the physical framework that supports movement and resilience.

The paper emphasizes that nutrition plays a significant role in chronic disease prevention. Functional ingredients may help regulate inflammation, oxidative stress, and metabolic balance, all of which influence long-term health outcomes and quality of life in companion animals.

Functional ingredients provide a science-based framework for supporting whole-body health in companion animals. Vitamins and minerals build the biochemical foundation of immune and metabolic activity, antioxidants help maintain oxidative balance, fatty acids regulate inflammation, fibers support gut health, phytonutrients offer additional protective effects, and structural nutrients contribute to connective tissue strength. Together, these nutritional strategies highlight the growing role of evidence-based functional nutrition in veterinary wellness and preventive care.

Stroke is a life-altering neurological event that frequently results in persistent motor deficits, speech impairment, cognitive decline, and reduced quality of life. It occurs when cerebral blood flow is interrupted or compromised and is broadly categorized into ischemic stroke, hemorrhagic stroke, and transient ischemic attack. Current standards of care including thrombolytic therapy, surgical intervention, and structured rehabilitation aim to restore perfusion, limit neurological damage, and optimize functional recovery. While these interventions have significantly improved acute survival, outcomes remain suboptimal in many patients, particularly those with extensive neurological injury (Yang et al., 2024). Growing scientific interest has therefore turned toward integrative strategies that complement conventional treatment. Emerging evidence suggests that targeted nutritional and phytochemical interventions such as vitamins, antioxidants, and anti-inflammatory compounds may influence key molecular pathways involved in oxidative stress, neuroinflammation, mitochondrial dysfunction, and neuroplasticity (Liang et al., 2022). This paper presents the case of a 62-year-old male stroke patient who underwent conventional therapy augmented with a structured natural medicine protocol. Through this case analysis, we explore how evidence-informed integrative approaches may support neurological recovery, reduce secondary complications, and enhance overall quality of life. The findings suggest that incorporating well-designed natural formulations into post-stroke care may provide a valuable adjunct to standard rehabilitation strategies.

Insulin resistance has emerged as a widespread global health concern that continues to challenge public health systems. This metabolic imbalance is increasingly recognized as a contributing factor to type 2 diabetes, cardiovascular disease, and a range of metabolic disorders. The economic burden associated with insulin resistance is substantial, as healthcare systems worldwide allocate significant resources toward managing diet-related metabolic conditions. Growing scientific interest in natural ingredients and nutraceutical approaches offers a complementary perspective alongside conventional medical therapies. Research suggests that specific bioactive compounds may influence insulin sensitivity, glycemic balance, and metabolic regulation through multiple biological pathways. The increasing demand for holistic wellness strategies and sustainable interventions has contributed to the popularity of natural approaches that emphasize metabolic balance and long-term lifestyle integration.

The current paper is a white paper discussing the scientific and industrial benefits of a patent pending coffee production method (Docket No.: Crahm2024-04), which offers a proprietary rinse formula intended to eliminate or reduce trace amounts of toxic chemicals in coffee beans, for example, pesticides. The invention is a mix of controlled storage, precise roasting, and two-phase rinsing with a zeolite-enhanced solution. Additionally, it will discuss the cumulative impact of this strategy on the science of coffee that involves toxicology, process engineering, sensory preservation, and sustainable production. This patent is a scalable, repeatable paradigm to take maximum steps in ensuring safety of coffee by reducing application of other established modes of decaffeination and detoxification methods without interfering with taste or the environment. The paper places the invention in the context of coffee research and describes current opportunities to create new inventions.